TOKYO, June 1 (Reuters) - Japan's Shionogi & Co said on Monday the U.S. Food and Drug Administration has approved its oral ...

The FDA on Monday approved the first medication for COVID-19 prevention that people can take after they have been exposed to ...

Red Cross workers talk to a woman in Bunia, Democratic Republic of Congo, to raise awareness about Ebola on Monday. (Reuters) ...

After a prior misfire in demonstrating its protease inhibitor ensitrelvir’s potential as a COVID-19 treatment for U.S. patients, Shionogi has secured an FDA green light for the medicine in the ...

In 2023-24, the latest year for which data was available, of the 2,98,180 US students studying abroad, only 1,578 chose India ...

During the volatile first quarter of 2026, the Lazard International Equity Portfolio rose 0.3% (net of fees), outperforming ...

Japanese pharmaceutical giant Mitsubishi Tanabe Pharma Corp. announced that a COVID-19 vaccine derived from a type of tobacco ...

The number of foreign exchange students in Japan as of May 2025 hit a record high of 408,069, ahead of a government goal to ...

A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.

More than 130,000 people in Japan have died from COVID-19 since the first confirmed case five years ago, the health ministry ...

As concerns grow over a hantavirus outbreak traced back to an Antarctic cruise, Britain has taken swift action by securing ...

The Japanese wedding market is a niche tourism segment that has yet to rebound despite initial growing arrival numbers from the country in the first few months of 2026.